Real-time enrollment status for this carcinoma, renal cell clinical trial
Current Status
Recruiting
Checked: November 12, 2026 at 9:55 AM UTC
| NCT Number | NCT07489495 |
| Recruiting Status | Recruiting |
| Condition | Carcinoma, Renal Cell |
| Phase | PHASE3 |
| Target Enrollment | 758 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | November 10, 2026 (2 days ago) |
As of November 12, 2026: Clinical trial NCT07489495 is currently recruiting participants. This phase3 study for carcinoma, renal cell is actively seeking new participants at 14 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07489495 is actively recruiting participants as of November 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07489495 was last updated 2 days ago (November 10, 2026). HelloStudys verifies this status automatically.